In a long‐term study of over 10 years post‐transplantation, all 4 MPS IVA patients demonstrated the maintenance of GALNS activity at donor levels, delay in skeletal dysmorphic progression without orthopedic surgery in an ambulant condition (Yabe et al., 2016). This evidence concerns the gene GALNS and mucopolysaccharidosis type 4A.